What is the WHO essential medicines list?

Epidemiology and Psychiatric Sciences

Volumn 21, Issue 4, 2012, Pages 343-345

  Purgato, M ^a   Barbui, C ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Essential list of medicines; mental health; psychotropic drugs; World Health Organization

Indexed keywords

AMITRIPTYLINE; CARBAMAZEPINE; CHLORPROMAZINE; CLOMIPRAMINE; DIAZEPAM; FLUOXETINE; FLUPHENAZINE; FLUPHENAZINE DECANOATE; HALOPERIDOL; LITHIUM CARBONATE; METHADONE; VALPROIC ACID;

ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DRUG DEPENDENCE; DRUG EFFICACY; DRUG SAFETY; ESSENTIAL MEDICINES LIST; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; NICOTINE REPLACEMENT THERAPY; OBSESSIVE COMPULSIVE DISORDER; PSYCHOSIS; REGISTER; WORLD HEALTH ORGANIZATION;

COST-BENEFIT ANALYSIS; DRUGS, ESSENTIAL; HUMANS; PSYCHOTROPIC DRUGS; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 84869380573     PISSN: 20457960     EISSN: 20457979     Source Type: Journal    
DOI: 10.1017/S204579601200039X     Document Type: Article

References (10)

1. Bloom BR (2011). WHO needs change. Nature 473, 143-145.
2. Hutchings J, Neroutsos K, Donnelly K (2010). Making the list: the role of essential medicines lists in reproductive health. International Perspectives on Sexual and Reproductive Health 36, 205-208.
3. Kishore SP, Herbstman BJ (2009). Adding a medicine to the WHO model list of essential medicines. Clinical Pharmacology and Therapeutics 85, 237-239.
4. Laing R, Waning B, Gray A, Ford N, Hoen E (2003). 25 years of the WHO essential medicines lists: progress and challenges. Lancet 361, 1723-1729. (Pubitemid 36577449)
5. Liberati A (2011). The Cochrane Collaboration as key player in the struggle for better and more relevant patients-and system-oriented research. Epidemiology and Psychiatric Sciences 20, 225-230.
6. Purgato M, Barbui C, Adams CE (2011). Using the needs of WHO to prioritise Cochrane reviews: the case of antipsychotic drugs. International Journal of Mental Health Systems 5, 25.
7. World Health Organization (2009). The Selection and Use of Essential Medicines. WHO: Geneva. Retrieved 5 June 2012 from http://whqlibdoc.who.int/trs/ WHO-TRS-958-eng.pdf
8. World Health Organization (2011a). Model List of Essential Medicines. WHO: Geneva. Retrieved 5 June 2012 from http://whqlibdoc.who.int/hq/2011/a95053- eng.pdf
9. World Health Organization (2011b). WHO List of rejected drugs from the list of Essential Medicines. WHO: Geneva. Retrieved 5 June 2012 from http://www.who.int/selection-medicines/committees/REJECTIONS.pdf
10. World Health Organization (2011c). mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings. WHO: Geneva. Retrieved 5 June 2012 from http://whqlibdoc. who.int/publications/ 2010/9789241548069-eng.pdf